AKU1 Akzo Nobel N.V.

AkzoNobel focuses on COVID-19 response, ready to resume momentum towards Winning together: 15 by 20 ambition when markets normalize

AkzoNobel focuses on COVID-19 response, ready to resume momentum towards Winning together: 15 by 20 ambition when markets normalize

March 31, 2020

AKZA; AKZOY

AkzoNobel focuses on COVID-19 response, ready to resume momentum towards Winning together: 15 by 20 ambition when markets normalize

AkzoNobel pauses key parts of the company’s transformation and suspend its 2020 financial ambition in response to significant market disruption resulting from the COVID-19 pandemic. Once markets normalize, AkzoNobel intends to resume its positive momentum and drive performance in line with industry frontrunners.

The company is taking maximum precautions to ensure the safety and well-being of its employees, while also taking all reasonable steps to sustain business operations and continue serving its customers. AkzoNobel takes care to fully support and comply with the requirements of relevant authorities. In affected countries and regions, employees are working remotely if their jobs allow.

As the situation continues to evolve, the company is constantly adapting its actions.

AkzoNobel CEO, Thierry Vanlancker, commented:

“It’s clear COVID-19 is having a huge impact – for you, for us at AkzoNobel, and for the whole world. Our priority right now is the health and safety of our employees, their families, and our partners. At the same time, we’re taking all reasonable steps to continue serving our customers, some of whom are relying on us to provide products across a whole range of critical industries.

“Headwinds related to COVID-19, including unpredictable and lower end market demand as well as various measures impacting our business operations, are increasing for most parts of the world and will have a significant impact during Q2. In China, activity is gradually returning to normal after being significantly impacted in Q1.

“The supply and demand balance and regulatory situation are complex, constantly evolving, and differs per region and segment. There is currently little reliable visibility on the second quarter, however we expect end market demand to be significantly below any of our previous expectations.

“We’re closely monitoring the pandemic situation and taking all necessary measures, including steps to rapidly reduce costs and carefully manage cash flows in the short-term. The significant market disruption forces us to pause key parts of our transformation and hence to suspend our 2020 financial ambition. Once markets normalize, we remain eager and passionate to resume our Winning together: 15 by 20 momentum to drive AkzoNobel’s performance in line with industry frontrunners.”

AkzoNobel has a strong balance sheet and solid cash position. At December 31, 2019, net cash and cash equivalents were €1.2 billion and financial leverage was 0.7x net debt/EBITDA. The company has a €1.3 billion unutilized revolving credit facility with a maturity of 2025. The next bond maturity is €750 million in July 2022. AkzoNobel is committed to retain a strong investment grade credit rating.

Financial results for the first quarter 2020 will be announced on April 22. The company will hold its Annual General Meeting of shareholders on April 23, 2020. Given the circumstances, AkzoNobel strongly encourages its shareholders to exercise their voting rights via proxy or to attend and vote virtually. As the situation continues to evolve, please check the company website for updates.

This is a public announcement by Akzo Nobel N.V. pursuant to section 17 paragraph 1 of the European Market Abuse Regulation (596/2014).

About AkzoNobel

AkzoNobel has a passion for paint. We’re experts in the proud craft of making paints and coatings, setting the standard in color and protection since 1792. Our world class portfolio of brands – including Dulux, International, Sikkens and Interpon – is trusted by customers around the globe. Headquartered in the Netherlands, we are active in over 150 countries and employ around 34,000 talented people who are passionate about delivering the high-performance products and services our customers expect.

Not for publication – for more information

Media RelationsInvestor Relations
T +31 (0)88 – 969 7833T +31 (0)88 – 969 7856
Contact: Diana Abrahams

Contact: Lloyd Midwinter

Safe Harbor Statement

This press release contains statements which address such key issues such as AkzoNobel’s growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest annual report, a copy of which can be found on our website:

Attachment

EN
31/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Akzo Nobel N.V.

Akzo Nobel N.V.: 2 directors

Two Directors at Akzo Nobel N.V. bought 45,963 shares at 60.400EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Release of 1Q24 company-compiled consensus. AkzoNobel: Decent 1Q24 with 4% beat, FY guidance reiterated. Allfunds Group plc: On the verge. Barco: Weak 1Q24, more conservative wording on guidance. DWS: 1Q24 preview. Flow Traders: No respite in March. IMCD: Last hurdle before growth. Randstad: 1Q24 slight miss vs consensus, 2Q24 outlook below due to weak gross margin. TKH Group: Preview – a weak 1Q expected Vår Energi: Nice start to the year

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AkzoNobel: 4Q23 narrowly misses, 2024 outlook, mid-term ambitions broadly in-line. Melexis: 4Q23 results; some weakness visible. UCB: Evenity going from one record to another. Universal Music Group: Supportive Spotify 4Q23 results

Stijn Demeester
  • Stijn Demeester

AkzoNobel/Model update ahead of 4Q23/HOLD

We update our model ahead of AkzoNobel's 4Q23 results, with our c.6% lower Adj. EBITDA estimates for 2024F-25F mainly explained by somewhat more moderate pricing assumptions and adverse FX trends. We increase our target price to €75 per share on the back of higher peer valuation multiples and reiterate our HOLD recommendation.

Stijn Demeester
  • Stijn Demeester

AkzoNobel/Model update post 3Q23/HOLD

We revise our estimates following AkzoNobel's 3Q23 results and lower our target price to €70 per share, mainly due to lower peer multiples. We maintain our HOLD rating.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch